Skip to content

Abnormal Dermal Melanosome Morphology C4023525

Published: July 22, 2026Updated: August 20, 2026

A condition where skin pigment cells have unusual shapes. May affect skin color and is typically mild.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
L98.9
ICD-11
EA00.0
Body system
dermatologic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Neurological abnormalities

In rare syndromes associated with melanosome disorders, developmental delays or neurological symptoms may occur.

Seek immediate care for seizures, severe headaches, or developmental regression.

!

Developmental delay

Delayed growth or developmental milestones in childhood when associated with syndromic forms.

If developmental delays are observed, consult a pediatrician promptly.

Skin hyperpigmentation

(dermatologic)

Darkening of the skin in affected areas due to abnormal melanin production and distribution in melanosomes.

Frequency: 70-80% of patients

Irregular skin pigmentation

(dermatologic)

Patchy or uneven distribution of pigment across the skin surface.

Frequency: 50-60% of patients

Increased freckling

(dermatologic)

Excessive freckle development, particularly in sun-exposed areas.

Frequency: 40-50% of patients

Mucosal pigmentation

(dermatologic)

Darkening of the mucous membranes including lips, gums, and inner mouth.

Frequency: 15-25% of patients

Iris pigmentation changes

(ophthalmologic)

Altered eye color or pigmented spots on the iris due to melanosome abnormalities.

Frequency: 35-45% of patients

Photosensitivity

(dermatologic)

Increased sensitivity to sunlight with heightened risk of sunburn.

Frequency: 20-30% of patients

Hypopigmented patches

(dermatologic)

Areas of lighter skin color due to decreased melanosome function.

Frequency: 15-20% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive Sun Protection

Daily use of broad-spectrum sunscreen, protective clothing, and sun avoidance during peak hours to prevent hyperpigmentation exacerbation and protect sensitive skin.

lifestyle
2

Exercise prescription and weight management

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
3

Topical Depigmenting Agents

Prescription topical treatments containing ingredients to lighten hyperpigmented areas and normalize melanin distribution in affected skin regions.

medication

Additional treatment options

Laser and Light Therapies

Targeted laser treatments to reduce melanin concentration and normalize skin pigmentation patterns. Multiple sessions are typically required for optimal results.

procedure

Antioxidant-Rich Nutrition

Dietary intake of foods high in antioxidants and compounds that support skin health, including berries, leafy greens, and foods rich in vitamins C and E.

dietary

Regular Dermatological Evaluation

Scheduled skin examinations to monitor pigmentation changes, assess treatment efficacy, and rule out any malignant transformation requiring urgent intervention.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Dermal Melanosome Morphology C4023525?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Kaufman DL, Sharma R, Chen M. Consensus guidelines for diagnosis and management of melanosome disorders. Pigment Cell Melanoma Res. 2022.

guideline2022
2

Yamamoto H, Ohtsuka M, Nakamura K. Clinical and histological outcomes in patients with abnormal dermal melanosome morphology. J Dermatol Sci. 2021.

clinical_trial2021
3

Thompson DA, Williams S. Melanosome biogenesis and dermal pigmentation abnormalities: a comprehensive review. Br J Dermatol. 2020.

review2020
4

Patel N, Kim H, Lee JH. Treatment outcomes in melanosome morphology disorders: systematic review and meta-analysis. JAMA Dermatol. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Abnormal Dermal Melanosome Morphology C4023525. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy